US › Healthcare

Moolec Science SA Ordinary Shares (MLEC)

US · Healthcare · Biotechnology

$0.850.00%

Last close · 2026-11-06

Latest quarter · ended 2025-03-31

Revenue

$2.6M

Revenue YoY

+25.3%

Net profit

$-2.4M

EPS

$-0.60

EPS estimate

$-0.60

Net margin

-91.8%

EPS came in at -0.60 against a street estimate of -0.60 — a beat of 0.0%.

Key statistics

Market cap

$617,200

Forward P/E

0.0

P/B

0.07

Book value

$0.70

EPS (TTM)

$-199.02

52-week high

$23.22

52-week low

$0.80

50-day MA

$4.32

200-day MA

$7.17

Beta

-0.32

Analyst view

with an average price target of $3.00.

Shareholding

Insiders

21.06%

Institutions

0.07%

Largest institutional holders

Fund	Stake
UBS Group AG	0.06%
Caitong International Asset Management Co., Limited.	0.00%
SBI Securities Co Ltd	0.00%
HRT FINANCIAL LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Moolec Science SA Ordinary Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.